A Quick Look at The Present and Immediate Future of Diabetes Mellitus Type 1


Ignacio Díez López* and S. Maeso Mendez

Department of Paediatrics, University of Basque Country, Bioaraba, Araba, Spain

*Corresponding Author:
Ignacio Díez López
Department of Paediatrics, University of Basque Country
Bioaraba, Araba, Spain
E-mail: idlcorreo@hotmail.com

Received: 05 March, 2024; Processed: 18 March, 2024; Accepted: 27 March, 2024

Citation: Lopez, ID. “A Quick Look at The Present and Immediate Future of Diabetes Mellitus Type 1.” J Diabet Clin Endocrinol (2024): 103. DOI: 10.59462/JDCE.1.1.103.

Copyright: © 2024 Lopez ID. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.



Editorial

Type 1 diabetes (T1DM) is a hyperglycaemic syndrome that results from the autoimmune destruction of pancreatic beta cells. To achieve good metabolic control, for which we have an excellent technological tool, continuous interstitial glucose monitoring (CGM), which should be used in all pediatric patients from diagnosis. Positive results of delay in the diagnosis of DM1 and lengthening of the remission phase have been obtained with the use of monoclonal antibodies. Without a doubt, the greatest current advances in the treatment of DM1 come from the use of technology, together with regulated/structured and continued diabetes education, this being a fundamental piece to improve control, adherence to treatment and quality. of patient’s lives [1,2] . Despite all the advances in general, the objectives advocated by international societies for this age (American Diabetes Association [ADA], International Society for Pediatric and Adolescent Diabetes [ISPAD]) have not been achieved, leading to the search for other systems that lead to greater adherence to treatment [3-5].

New ultra-rapid-acting insulins, such as new insulin pumps, allow for improved postprandial glycaemic control. However, the main advances in recent decades have come from the use of insulin pumps, the use of CGM systems and the association of both, along with automatic stop algorithms and other automatic insulin release algorithms, since available in the clinic. This, together with the wireless download of data on specific platforms, most of it through the cloud, has made it possible to share it with their caregivers (parents, teachers, diabetologists) in real time and achieve better daily adjustment of the treatment. It should be noted that in the coming years the challenge will be to be able to provide a better quality of life and lengthen the “honeymoon” time of patients in a pre- DM1 state, through the possible use of immunoregulatory drugs, such as anti-CD3 recently approved by the FDA.

The challenge will then be to screen or detect these “pre- DM” cases. The Government of Italy this October has created a Law in this sense aimed at screening for Type 1 DM in children. We cannot forget the importance of the child in school and his education. The school life of a boy or girl with diabetes is no different from that of the rest, nor should it represent any problem for the school. Generally, a child with diabetes must take insulin during school hours. That is why teachers must know treatments, as well as the situations that may occur during the school day.

Maintaining a fluid exchange of information between families and the school will help the child keep their diabetes under control. Furthermore, the better informed the school is, the easier it will be to collaborate. The diet of a boy or girl with type 1 diabetes must be healthy and balanced, appropriate for their age, except for quickly absorbed sugars (candy, sweets and drinks, such as soft drinks and juices) because they can greatly increase blood glucose. We must insist there is no diet for diabetic children, but the child with type 1 DM must adapt his carbohydrate intake and insulin needs in the dining room, but he can eat anything with measure and control. Clara, depending on her age, will require help for this. The question is WHO educators, teachers, caregivers, school or external nurses? tricky issue and source of debate.

It is recommended to facilitate parents weekly planning of the school menu so that they can make the necessary occasional adjustments. For example, for yogurt to be equivalent to a piece of fruit for dessert, it must be fruit, flavored or sugary. It is important to respect the child’s meal schedule. They may require having a second breakfast coinciding with mid-morning recess time. If there is a celebration in class, the teacher should know how to act. Therefore, communication with the family must be fluid.

The boy or girl with type 1 diabetes can and should do the same exercise as his or her classmates. Exercise can cause blood sugar to drop. To avoid this, it is recommended that the child eat carbohydrate food before exercising. The family can guide teachers on the measures to adopt. It is convenient for the physical education teacher to have easy access to foods with sugars in case of hypoglycemia. Exercise is contraindicated in case of glycaemic decompensation (hyperglycemia and hypoglycemia). What adverse situations can a teacher encounter related to diabetes and should they manage? Well, above all, we have to look at hypoglycemia and detect ketosis if there is hyperglycemia.

The educator must not forget that The child with type 1 diabetes faces a chronic illness that involves making many decisions every day. Depending on his age, he is capable of making many of these decisions. However, all of this can have an impact on your mood and even school performance if metabolic control is not adequate.

References

  1. Zhong, Ting, Rong Tang, Siyuan Gong and Juan Li, et al. “The Remission Phase in Type 1 Diabetes: Changing Epidemiology, Definitions and Emerging Immuno-Metabolic Mechanisms.” Diabetes Metab Res Rev 36 (2020): e3207.
  2. Nimri, Revital, Judith Nir and Moshe Phillip. “Insulin Pump Therapy.” Am J Ther 27 (2020): e30-e41.
  3. Battelino, Tadej, Thomas Danne, Richard M. Bergenstal and Stephanie A Amiel, et al. “Clinical Targets for Continuous Glucose Monitoring Data Interpretation: Recommendations from the International Consensus on Time in Range.” Diabetes care 42 (2019): 1593-1603.
  4. Messer, Laurel H., Cari Berget and Gregory P. Forlenza. “A Clinical Guide to Advanced Diabetes Devices and Closed-Loop Systems Using the Cares Paradigm.” DiabetesTechnolTher21 (2019): 462-469.
  5. Lopez, IGNACIO Diez and Sandra Maeso Mendez. “A Quick Look at the Present and Immediate Future of Type 1 DM.” (2024).